2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Revenue | $3.5B | $5.7B | $6.3B | $5.1B | $4.6B |
Cost of Revenue | $2.8B | $4.5B | $5B | $4.1B | $3.8B |
Gross Profit | $621M | $1.1B | $1.3B | $1B | $834M |
Gross Profit % | 18% | 20% | 21% | 20% | 18% |
R&D Expenses | $0 | $0 | $0 | $0 | $0 |
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Net Income | -$65M | $295M | $392M | $146M | -$7.3M |
Dep. & Amort. | $54M | $56M | $59M | $63M | $78M |
Def. Tax | -$17M | $600K | $7.4M | $17M | -$9.8M |
Stock Comp. | $1.9M | $5.5M | $9.1M | $14M | $12M |
Chg. in WC | $229M | -$348M | $36M | $122M | $120M |
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Cash | $61M | $51M | $39M | $54M | $28M |
ST Investments | $0 | $0 | $0 | $0 | $0 |
Cash & ST Inv. | $61M | $51M | $39M | $54M | $28M |
Receivables | $390M | $652M | -$57M | $487M | $426M |
Inventory | $605M | $832M | $799M | $783M | $685M |
Ryerson completed a significant CapEx cycle aimed at modernizing operations, with expectations for improved earnings and operational efficiency starting in 2025 and beyond.
Q4 2024 sales volume decreased by 7.8% quarter-over-quarter, reflecting seasonality and weaker demand, but volumes are expected to increase by 11%-13% sequentially in Q1 2025.
Revenue guidance for Q1 2025 is $1.12 billion to $1.15 billion, with adjusted EBITDA (excluding LIFO) expected to range between $28 million and $32 million.
Net debt leverage ended Q4 2024 at 3.9x, above the long-term target of 0.5x-2x, but management plans to normalize leverage as business conditions improve in 2025.
Ryerson plans to reduce CapEx to $50-$55 million in 2025, focusing on operationalizing recent investments and improving cash flow generation.